Logo
  • What are Pemphigus
    and Pemphigoid
    • Find a Doctor
    • Diagnosis
    • Pemphigus
    • Pemphigoid
    • Treatments
    • Patient Stories
  • Patients
    • Peer Coaches
    • Patient Education Webinars
    • Support Groups
    • Prescription Assistance
    • Patient Resources
    • IPPF Natural History Study
    • Clinical Trial Information for Patients
    • Information Related to COVID-19
  • Healthcare
    Professionals
    • P/P Clinical Information
      • Diagnostics
      • Biopsies Save Lives
      • Disease Outcomes
      • Disease Management
    • Research Grants
    • Clinical Trials
    • Registry Substudy Info
    • Resources for Healthcare Professionals
    • Student and Continuing Education
  • About
    Us
    • Our Programs
    • Board of Directors
    • Staff & Coaches
    • Advisors
    • Financials
    • Employment
    • Contact Us
  • Get
    Involved
    • Volunteer
    • Become an Advocate
    • Ways to Give
    • Fundraise
  • News &
    Events
    • Events
    • Quarterly
    • PemPress
  • Donate
This is the Pempress Logo

the IPPF news site

Women's Dermatological Society
August 4, 2022
Women’s Dermatological Society Features the IPPF in Editorial Highlight

An interview between Dr. Brittney Schultz and Becky Strong, IPPF Outreach Director, was published by the Women's Dermatological Society on June 27, 2022 and highlights the importance and value for physicians...

KSL Beutner Laminin
July 28, 2022
KSL Beutner Laboratories Launches First Blood Test for Chronic, Debilitating Autoimmune Disease

Highly accurate IIF serological assay for Laminin 332 Mucous Membrane Pemphigoid reduces the wait for confirmed diagnosis from months or years to 72 hours or less On July 27, 2022 KSL...

International Alliance of Dermatology Patient Organizations
July 11, 2022
The IPPF Joins Newly Launched Global Dermatology Coalition

The following was published on May 25, 2022 in Practical Dermatology. The Global Dermatology Coalition, a patient-led, multi-stakeholder group of organizations, has launched during the 75th World Health Assembly in Geneva. The Global...

July 5, 2022
Role of the IPPF During the COVID-19 Pandemic

The following Letter to the Editor was published in the Journal of the European Academy of Dermatology and Venereology on April 25, 2022 about the role of the IPPF during...

Akari Therapeutics
June 6, 2022
Akari Therapeutics Announces Publication of Phase II Data of Nomacopan for Bullous Pemphigoid Treatment

Akari Therapeutics recently announced that positive results from the Phase II study of investigational nomacopan in bullous pemphigoid (BP) were published online in the Journal of the American Medical Association (JAMA). ...

COVID-19 vaccine and blue gloves
April 21, 2022
COVID-19 Vaccine Acceptance and Hesitancy in Patients with Autoimmune Bullous Diseases

The following was published as a Letter to the Editor in the British Journal of Dermatology in November, 2021. The letter outlines a cross-sectional study of COVID-19 vaccine acceptance and...

1 2 3 … 27 Next
What are Pemphigus and Pemphigoid
Patients
Healthcare Professionals
Logo

The International Pemphigus & Pemphigoid Foundation’s most important objectives are to provide patients and doctors worldwide with information about pemphigus and pemphigoid.

Donate

Site map

  • What are Pemphigus
    and Pemphigoid
  • Patients
  • Healthcare
    Professionals
  • About
    Us
  • Get
    Involved
  • News &
    Events
  • Donate

Contact

International Pemphigus & Pemphigoid Foundation
915 Highland Pointe Dr, Ste 250
Roseville, CA 95678
United States of America
info@pemphigus.org
(855) 473-6744 – (916) 922-1298

© 2022 International Pemphigus & Pemphigoid Foundation. All Rights Reserved.

Website Design for Nonprofits by Elevation Web
en English▼
X
ar Arabicbn Bengalizh-CN Chinese (Simplified)en Englishfr Frenchde Germanel Greekiw Hebrewhi Hindiit Italianja Japanesefa Persianpt Portuguesepa Punjabiru Russianes Spanishth Thaivi Vietnamese